<DOC>
	<DOCNO>NCT02373163</DOCNO>
	<brief_summary>This trial design : 1 . Assess response montherapy : thiazide diuretic ( HCTZ ) , calcium-channel blocker ( CCB , amlodipine ) angiotensin-receptor blocker ( telmisartan ) , among hypertensive subject live sea level , medium altitude sea level high altitude sea level . 2 . To test whether diferentes exist response therapy among subject live different altitude sea level 3 . To assess hemodynamic characteristic hypertension population live sea level , medium altitude sea level , high altitude sea level .</brief_summary>
	<brief_title>INTERVENCION Trial</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>1 . Age 4575 year . Enrollment stratify age group ( 5065 6680 year ) , gender altitude sea level 2 . Leaving enrollment city least 2 year 3 . Untreated hypertension least 2 week 4 . Systolic BP 140 160 mmHg and/or diastolic BP 90 99 mmHg , absence therapy . 1 . Diabetes mellitus . 2 . Chronic kidney disease ( estimate glomerular filtration rate &lt; 60 ml / minute / 1.73 m2 body surface area . 3 . Smoking . 4 . Lung disease , liver disease active cancer 5 . Any factor , opinion investigator , decrease shortterm survival 6 . Psychiatric illness 7 . Inability provide inform consent 8 . Established heart disease ( previous myocardial infarction , heart failure , valvular heart disease , cardiomyopathy , atrial fibrillation significant cardiac arrhythmia ) 9 . History cerebrovascular disease 10 . History orthostatic hypotension . 11 . History syncope . 12 . History allergy adverse effect study medication drug pharmacologic class .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>